EMEA-002827-PIP01-20-M02
Submitted by Anonymous (not verified) on 4 October 2024 - 15:31
EMEA-002827-PIP01-20-M02
EMEA-002681-PIP01-19-M02
Submitted by Anonymous (not verified) on 4 October 2024 - 15:21
EMEA-002681-PIP01-19-M02
EMEA-002722-PIP01-19-M03
Submitted by Anonymous (not verified) on 4 October 2024 - 15:11
EMEA-002722-PIP01-19-M03
EMEA-002485-PIP01-18-M01
Submitted by Anonymous (not verified) on 4 October 2024 - 15:00
EMEA-002485-PIP01-18-M01
European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure: document with tracked changes
Submitted by Anonymous (not verified) on 4 October 2024 - 14:45
European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure: document with tracked changes
European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure
Submitted by Anonymous (not verified) on 4 October 2024 - 14:45
European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure
Opinion/decision on a Paediatric investigation plan (PIP): Xofluza, Baloxavir marboxil, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infectious diseases, PIP number: P/0359/2023
Submitted by Anonymous (not verified) on 4 October 2024 - 14:42
Opinion/decision on a Paediatric investigation plan (PIP): Xofluza, Baloxavir marboxil, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infectious diseases, PIP number: P/0359/2023
EMEA-003436-PIP01-23
Submitted by Anonymous (not verified) on 4 October 2024 - 14:37
EMEA-003436-PIP01-23
EMEA-003438-PIP01-23
Submitted by Anonymous (not verified) on 4 October 2024 - 14:37
EMEA-003438-PIP01-23
EMEA-003444-PIP01-23
Submitted by Anonymous (not verified) on 4 October 2024 - 14:37
EMEA-003444-PIP01-23